4881 · Growth
FunPep Company Limited
Pharmaceutical · Stock price, valuation and financial results
View watchlist →Share prices may be delayed. Price date: 2026-11-02. Figures are provided for research and are not investment advice.
Market data
Share price¥40
Market capitalization¥1,622,552,000
P/E ratioData unavailable
P/B ratio1.13×
Dividend yield0%
Financials
Latest fiscal year: 2025
Revenue¥314,000
Operating income-¥1,648,668,000
Net income-¥1,911,527,000
Return on equity-130.56%
Equity ratio73.91%
Share price history
Historical prices reflect the available market data. Use the date shown with each quote.
191 trading days
2026-11-02Open 40High 41Low 40Close 40Volume 192,300
Drag to pan · scroll to zoom
Five-year financial history
| Fiscal year | Revenue | Operating income | Net income | Equity |
|---|---|---|---|---|
| 2025 | ¥314,000 | -¥1,648,668,000 | -¥1,911,527,000 | ¥1,464,133,000 |
| 2024 | ¥6,127,000 | -¥901,758,000 | -¥889,092,000 | ¥2,547,478,000 |
| 2023 | ¥530,000 | -¥994,108,000 | -¥933,416,000 | ¥2,301,809,000 |
| 2022 | ¥1,067,000 | Data unavailable | -¥1,172,515,000 | ¥2,694,585,000 |
J-KABU Score
PRO ONLY
11-factor stock score
Checking membership…
PRO ONLY
AI stock analysis
Checking membership…
Industry peers
Companies in the same sector, ordered by market capitalization. Compare the underlying dates before drawing conclusions.
| Company | P/E | P/B | Dividend yield | ROE |
|---|---|---|---|---|
| CHUGAI PHARMACEUTICAL CO.,LTD. (4519) | 25.95x | 5.67x | 1.93% | 21.42% |
| Takeda Pharmaceutical Company Limited (4502) | Data unavailable | 3.21x | 3.07% | -4.62% |
| Otsuka Holdings Co.,Ltd. (4578) | 17.18x | 2.11x | Data unavailable | 11.97% |
| DAIICHI SANKYO COMPANY,LIMITED (4568) | 20.6x | Data unavailable | 3.46% | 5.97% |
| Astellas Pharma Inc. (4503) | 15.78x | 2.54x | 3.11% | 15.94% |
| Shionogi & Co.,Ltd. (4507) | 18.73x | 2.96x | 2.51% | 8.24% |
Company names without a verified English form are shown in their registered Japanese form.